UCLA Hematology Oncology — Los Angeles, California

UCLA Hematology Oncology is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematology Oncology has participated in 12 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Metastatic Breast Cancer, Carcinoma, Non-Small-Cell Lung.

Sponsors: Daiichi Sankyo, Pfizer, Celgene.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology Oncology?

UCLA Hematology Oncology has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology Oncology conducted?

UCLA Hematology Oncology has 12 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Metastatic Breast Cancer, Carcinoma, Non-Small-Cell Lung.

Is UCLA Hematology Oncology accredited by Crixeo Health?

Yes — UCLA Hematology Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UCLA Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.